Oral Motor Parafunctions Among Heavy Drug Addicts and Their Effects on Signs and Symptoms of Temporomandibular Disorders

Aims: To investigate the prevalence of temporomandibular disorders (TMD), bruxism, and other oral habits among drug addicts compared to a normal, non-addicted, matched control population, and to assess the detrimental effect of long-term drug abuse on the parameters studied. Methods: Subjects included 55 drug-addicted patients (51 males and 4 females) randomly selected from longterm addicts using “hard” narcotics and attending a methadone maintenance center and a control group of 52 normal non-addicted individuals (48 males and 4 females) matched to the addicts for age, gender, and socioeconomic status. A clinical examination and a questionnaire were used. One examiner determined that all questions were correctly understood and answered, and a second examiner performed the clinical examinations and was unaware of the results of the questionnaire. Results: The addicted group had a high prevalence of orofacial motor behavior (bruxing, clenching) as well as signs and symptoms of TMD (morning headache, joint noises, joint and masticatory muscle tenderness to palpation, and tooth wear) compared to the controls. Active (voluntary) jaw opening was significantly smaller, although within an acceptable range when compared to the controls. Conclusion: Long-term drug abuse detrimentally affects the stomatognathic system, as expressed in a high prevalence of oral motor behavior and signs and symptoms of TMD.

substance-abuse disorders; bruxism; oral motor parafunctions; temporomandibular disorders

1. Lavigne GJ, Montplaisir JV. Bruxism: Epidemiology, diagnosis, pathophysiology, and pharmacology. In: Fricton JR, Dubner R (eds). Advances in Pain Research and Therapy. Vol 21: Orofacial Pain and Temporomandibular Disorders. New York: Raven Press, 1995:387–404.

2. Lambert RW, Goldberg LJ, Chandler SH. Comparison of mandibular movement trajectories and associated patterns of oral muscle electromyography. Activity during spontaneous and apomorphine-induced rhythmic jaw movements in the guinea pig. J Neurophysiol 1986;55:301–319.

3. Gerstner GE, Goldberg LJ, De Bruyne K. Angiotensin II-induced rhythmic jaw movements in the ketamine-anesthetized guinea pig. Brain Res 1989;478:233–240.

4. Koshikawa N, Koshikawa F, Tomiyana T, Kikuchi de Beltran K, Kamimura F, Kobayashi M. Effects of dopamine D1 and D2 agonists and antagonists injected into the nucleus accumbens and globus pallidus on jaw movements on rats. Eur J Pharmacol 1990;182:375–380.

5. Waddington JL. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: Phenomenlogy, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacol 1990;101:431–447.

6. Gomez FM, Areso MP, Giralt MT, Sainz B, Garcia-Vallejo P. Effects of dopaminergic drugs, occlusal disharmonies, and chronic stress on non-functional masticatory activity in the rat, assessed by incisal attrition. J Dent Res 1998;77:1454–1464.

7. Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JV. The effect of the catecholamine precursor L-dopa on sleep bruxism: A controlled clinical trial. Mov Disord 1997;12:73–78.

8. Micheli F, Pardal MF, Gatto M, Asconape J, Giannaula R, Parera IC. Bruxism secondary to chronic antidopaminergic drug exposure. Clin Neuropharmacol 1993;16:315–323.

9. Fitzgerald K, Healy D. Dystonias and dyskinesias of the jaw associated with the use of SSRIs. Hum Psychopharmacol 1995;10:215–219.

10. Amir I, Hermesh H, Gavish A. Bruxism secondary to antipsychotic drug exposure: A positive response to propranolol. Clin Neuropharmacol 1997;20:86–89.

11. Montgomery MT, Nishioka GJ, Rugh JD, Thrash WJ. Effect of diazepam on nocturnal masticatory muscle activity. J Dent Res 1986;65:180.

12. Chasin AL. Methocarbamol (Robaxin) as an adjunct in the treatment of bruxism. J Dent Med 1959;14:166–169.

13. Ware JC, Rugh JD. Destructive bruxism: Sleep stage relationship. Sleep 1988;11:172–181.

14. Mohamed SE, Christensen LV, Penchas J. A randomized double-blind clinical trial of the effect of amitriptyline on nocturnal masseteric motor activity (sleep bruxism). J Craniomandib Pract 1997;15:326–332.

15. Hartman E. Bruxism. In: Kryger MH, Roth T, Dement WC (eds). Principles and Practice of Sleep Medicine, ed 2. Philadelphia:Saunders, 1994:598–601.

16. Takeuchi Y, Satoda T, Tashiro T, Matsushima R, Uemura-Sumi M. Amygdaloid pathway to the trigeminal motor nucleus via the pontine reticular formation in the rat. Brain Res Bull 1988;21:829–833.

17. Nishioka GJ, Montgomery MT. Masticatory muscle hyperactivity in temporomandibular disorders: Is it an extrapyramidally expressed disorder? J Am Dent Assoc 1988;116:514–520.

18. Scharer P, Kasahara Y, Kawamura Y. Tooth contact patterns during stimulation of the rabbit brain. Arch Oral Biol 1967;12:1041–1051.

19. Di Chiara G, Acquas E, Tanda G, Cadoni C. Drugs of abuse: Biochemical surrogates of specific aspects of natural reward? Biochem Soc Symp 1993;59:65–81.

20. Koob GF, Weiss F. Neuropharmacology of cocaine and ethanol dependence. Rec Dev Alcohol 1992;10:201–233.

21. Koob GF, Le Moal M. Drug abuse: Hedonic homeostatic dysregulation. Science 1997;278:52–58.

22. Kiyatkin EA. Dopamine mechanisms of cocaine addiction. Int J Neurosci 1994;78:75–101.

23. Di Chiara G. A motivational hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol 1998;12:54–57.

24. Spyraki C, Nomikos G. On the role of serotonin in drug reward: Studies with the place conditioning procedure. Pol J Pharmacol Pharm 1991;43:221–229.

25. Dworkin SF, LeResche L. Research Diagnostic Criteria for Temporomandibular Disorders: Review, Criteria, Examination and Specifications, Critique. J Craniomandib Disord Facial Oral Pain 1992;6:301–355.

26. Johansson A, Haraldson T, Omar R, Kiliaridis S, Carlsson GE. A system for assessing the severity and progression of occlusal tooth wear. J Oral Rehabil 1993;20:125–131.

27. Dixon WJ (ed). BMDP Statistical Software. Berkeley: Univ of California Press, 1990.

28. Ashcroft GW, Eccleston D, Waddell JL. Recognition of amphetamine addicts [letter]. Br Med J 1965;1:57.

29. Friedlander AH, Gorelick A. Dental management of cocaine addicts. Oral Surg Oral Med Oral Pathol 1988;65:45–48.

30. Peroutka SJ, Newman H, Harris H. Subjective effects of 3,4-methylenedioxy-methamphetamine in recreational users. Neuropsychopharmacol 1988;1:273–277.

31. Takahama Y. Bruxism. J Dent Res 1961;40:227.

32. Agerberg G, Carlsson GE. Functional disorders of the masticatory system. Acta Odontol Scand 1972;30:597–613.

33. Fricton JR, Schiffman EL. Epidemiology of temporomandibular disorders. In: Fricton JR, Dubner R (eds). Advances in Pain Research and Therapy. Vol 21: Orofacial Pain and Temporomandibular Disorders. New York: Raven Press, 1995:1–14.

34. Rugh JD, Ohrbach R. Occlusal parafunction. In: Mohl ND, Zarb GA, Carlsson GE, Rugh JD (eds). A Textbook of Occlusion. Chicago: Quintessence, 1988:249–256.

35. Gavish A, Halachmi M, Winocur E, Gazit E. Oral habits and their association with signs and symptoms of temporomandibular disorders in adolescent girls. J Oral Rehabil 2000;27:22–32.

36. Carlson KR. A syndrome resembling tardive dyskinesia which results from chronic methadone treatment. Psychopharmacol Bull 1978;14:76–77.

37. Catalano G, Catalano MC, Rodriguez R. Dystonia associated with crack use. South Med J 1997;90:1050–1052.

38. Wasserman S, Yahr MD. Choreic movements induced by the use of methadone. Arch Neurol 1980;37:727–728.